Signal Explorer
10-K · 10-Q · 8-K · last 6 months · ← back to feed
BioRestorative Therapies, Inc.
BRTX
Core
Management Exodus
Other
Severance Payment Obligation
Executive Severance Change Of Control
Other
Reverse Stock Split Effected
Fractional Share Cash Payment
Nyse Listing Disclosure
Equity Plan Board Approval Conditional On Shareholder Vote
Gene Therapy Aav
Core
Lead Asset Progress
Other
Auditor Appointment Ratification
Executive Educational Background Disclosure
Director Officer Indemnification Provision
Auditor Change
Amendment Modification Waiver Clause
New York Jurisdiction Clause
Indemnification Consent Requirement
Termination For Material Breach Clause
Director Continuity Stated
Audit Committee Independence Certification
Core
Management Exodus
Other
Nasdaq Minimum Bid Price Delisting Notice
Nyse Listing Disclosure
Other
Executive Educational Background Disclosure
Classified Board Director Election
Board Committee Composition Disclosure
Audit Committee Independence Certification
Employee Director Compensation Waiver
Core
Management Exodus
Other
Executive Educational Background Disclosure
Use Of Proceeds Disclosure
Board Committee Composition Disclosure
Classified Board Director Election
Employee Director Compensation Waiver
Non Employee Director Compensation Disclosed
Event Of Default Defined
Debt Note Interest Terms Disclosed
Core
Management Exodus
Other
Abstention Voting Treatment Disclosure
Other
Warrant Valued Black Scholes
Material Weakness In Internal Controls Disclosed
Nasdaq Minimum Bid Price Delisting Notice
Cash Flow Statement Investing Activities
Financing Activities Cash Flow Disclosure
Net Loss Reported
Liquidity Position Snapshot Disclosed
Institutional Investment
Personnel Cost Decrease Disclosure
Shares Outstanding Disclosure
Other Income Expense Disclosure
Codm Segment Reporting Disclosure
Ipo Net Proceeds Disclosure
Quarterly Dividend Declared
Ipo Or Capital Raising Completion
Other
Nasdaq Minimum Bid Price Delisting Notice
Share Repurchase Activity Disclosed
Depreciation Expense Composition Disclosure
Net Loss Reported
Material Weakness In Internal Controls Disclosed
Auditor Appointment Ratification
Ipo Net Proceeds Disclosure
Ipo Or Capital Raising Completion
Stock Price As Of Filing Date
Enrollment Ahead Of Schedule
Cash Flow Statement Investing Activities
Stock Option Grant Disclosed
Nol Carryforward Expiration Disclosure
Equity Plan Board Approval Conditional On Shareholder Vote
Institutional Investment